Novavax Stock Soars on a $1.6 Billion U.S. Infusion for #Covid19Vaccine https://t.co/HQ0RoprArg $NVAX $ATOS $JNJ "announcing that the U.S. government had awarded it $1.6 billion to test &amp; manufacture its Covid-19 vaccine. The company will deliver 100 million doses of the vaccine"